| 1 | Schizophr. Res. 2011 May 128: 37-43 |
|---|---|
| PMID | 21303731 |
| Title | Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. |
| Abstract | Postmortem and genetic studies have clearly demonstrated changes in GABA(B) receptors in neuropsychiatric disorders such as autism, bipolar disorder, major depression, andschizophrenia. Moreover, a number of recent studies have stressed the importance of cerebellar dysfunction in these same disorders. In the current study, we examined protein levels of the two GABA(B) receptor subunits GABBR1 andGABBR2从我们在侧小脑ll-characterized cohort of subjects withschizophrenia(n=15), bipolar disorder (n=14), major depression (n=13) and healthy controls (n=12). We found significant reductions in protein for both GABBR1 andGABBR2in lateral cerebella from subjects withschizophrenia, bipolar disorder and major depression when compared with controls. These results provide further evidence of GABAergic dysfunction in these three disorders as well as identify potential targets for therapeutic intervention. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 2 | Transl Psychiatry 2013 -1 3: e303 |
| PMID | 24022508 |
| Title | Expression of GABAA ?2-, ?1- and ?-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. |
| Abstract | There is abundant evidence that dysfunction of the ?-aminobutyric acid (GABA)ergic signaling system is implicated in the pathology ofschizophreniaand mood disorders. Less is known about the alterations in protein expression of GABA receptor subunits in brains of subjects withschizophreniaand mood disorders. We have previously demonstrated reduced expression of GABA(B) receptor subunits 1 and 2 (GABBR1 andGABBR2) in the lateral cerebella of subjects withschizophrenia, bipolar disorder and major depressive disorder. In the current study, we have expanded these studies to examine the mRNA and protein expression of 12 GABA(A) subunit proteins (?1, ?2, ?3, ?5, ?6, ?1, ?2, ?3, ?, ?, ?2 and ?3) in the lateral cerebella from the same set of subjects withschizophrenia(N=9-15), bipolar disorder (N=10-15) and major depression (N=12-15) versus healthy controls (N=10-15). We found significant group effects for protein levels of the ?2-, ?1- and ?-subunits across treatment groups. We also found a significant group effect for mRNA levels of the ?1-subunit across treatment groups. New avenues for treatment, such as the use of neurosteroids to promote GABA modulation, could potentially ameliorate GABAergic dysfunction in these disorders. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 3 | Brain Behav. Immun. 2016 Jan 51: 119-30 |
| PMID | 26254231 |
| Title | Disruptions of sensorimotor gating, cytokines, glycemia, monoamines, and genes in both sexes of rats reared in social isolation can be ameliorated by oral chronic quetiapine administration. |
| Abstract | The pathogenesis ofschizophreniain patients with metabolic abnormalities remains unclear. Our previous study demonstrated that isolation rearing (IR) induced longitudinal concomitant changes of pro-inflammatory cytokine (pro-CK) levels and metabolic abnormalities with a developmental origin. However, the general consensus, believes that these abnormalities are caused by antipsychotic treatment inschizophrenicpatients. The IR paradigm presents with face, construct, and predictive validity forschizophrenia. Therefore, we employed IR rats of both sexes to examine whether chronic quetiapine (QTP, a second-generation antipsychotic medication) treatment induces disruptions of metabolism (body weight, blood pressure, and the glycemic and lipid profiles) or cytokines [interleukin (IL)-1 beta, IL-6, IL-10, interferon-gamma, and tumor necrosis factor (TNF)-alpha], and further, whether it reverses deficits of behaviors [locomotor activity and prepulse inhibition (PPI)] and the expression of monoamines (dopamine and serotonin) and related genes (Htr1a, Htr2a, Htr3a, Drd1a, andGABBR2). IR induced higher levels of pro-CK, dysglycemia, blood pressure, locomotor activity, and impaired PPI, simultaneously destabilizing cortico-striatal monoamines and relevant genes in both sexes, while QTP demonstrated dose-dependent reversal of these changes, suggesting that QTP might reduce the pro-CKs to regulate these abnormalities. Our data implied that antipsychotics may not be the solitary factor causing metabolic problems inschizophreniaand suggested that inflammatory changes may play a vital role in the developmental pathophysiology ofschizophreniaand related metabolic abnormalities. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 4 | Brain Behav. Immun. 2016 Jan 51: 119-30 |
| PMID | 26254231 |
| Title | Disruptions of sensorimotor gating, cytokines, glycemia, monoamines, and genes in both sexes of rats reared in social isolation can be ameliorated by oral chronic quetiapine administration. |
| Abstract | The pathogenesis ofschizophreniain patients with metabolic abnormalities remains unclear. Our previous study demonstrated that isolation rearing (IR) induced longitudinal concomitant changes of pro-inflammatory cytokine (pro-CK) levels and metabolic abnormalities with a developmental origin. However, the general consensus, believes that these abnormalities are caused by antipsychotic treatment inschizophrenicpatients. The IR paradigm presents with face, construct, and predictive validity forschizophrenia. Therefore, we employed IR rats of both sexes to examine whether chronic quetiapine (QTP, a second-generation antipsychotic medication) treatment induces disruptions of metabolism (body weight, blood pressure, and the glycemic and lipid profiles) or cytokines [interleukin (IL)-1 beta, IL-6, IL-10, interferon-gamma, and tumor necrosis factor (TNF)-alpha], and further, whether it reverses deficits of behaviors [locomotor activity and prepulse inhibition (PPI)] and the expression of monoamines (dopamine and serotonin) and related genes (Htr1a, Htr2a, Htr3a, Drd1a, andGABBR2). IR induced higher levels of pro-CK, dysglycemia, blood pressure, locomotor activity, and impaired PPI, simultaneously destabilizing cortico-striatal monoamines and relevant genes in both sexes, while QTP demonstrated dose-dependent reversal of these changes, suggesting that QTP might reduce the pro-CKs to regulate these abnormalities. Our data implied that antipsychotics may not be the solitary factor causing metabolic problems inschizophreniaand suggested that inflammatory changes may play a vital role in the developmental pathophysiology ofschizophreniaand related metabolic abnormalities. |
| SCZ Keywords | schizophrenia, schizophrenic |